Paper

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021.

Published Aug 15, 2021 · H. Van Poppel, M. Roobol, C. Chapple

European urology

133

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Literature Review

Highly Cited

Study Snapshot

The European Association of Urology recommends a risk-adapted strategy for early prostate cancer detection, involving PSA testing, risk calculators, and multiparametric magnetic resonance imaging, to reduce advanced-stage diagnosis and improve quality of life for well-informed men.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021.

References

Citations